- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05433662
Telehealth Acceptance and Commitment Therapy for Older Veterans Experiencing Pandemic-Related Stress (Pan-ACT)
Pandemic Acceptance and Commitment Therapy (Pan-ACT): Feasibility and Acceptability of Telehealth Delivery With Older Veterans
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Significance: Accounting for over 80% of COVID-19 related deaths in the United States, adults ages 65 and older have been disproportionately impacted by this pandemic more than any other age group. As a result, they may bear a heavy psychological burden in the months and years to come. Older adults have been labeled "vulnerable" to COVID-19 and strongly encouraged to adhere to "social distancing." This prevention measure is meant to mitigate the spread of the virus but has increased older adults' risk of social isolation and loneliness, which are two known correlates of increased morbidity and mortality in late life. Pandemic-related restrictions have decreased older adults' life-space mobility and negatively affected their physical and nutritional well-being, impairing their quality of life and potentially increasing their vulnerability to poorer outcomes if exposed to COVID-19. Research has documented a plethora of pandemic-related stressors that are common among older adults (e.g., fear of infection, loss of loved ones, financial repercussions) and the culminating psychological impact. Telehealth-adapted evidence-based psychological interventions are needed to address the psychosocial and physical toll of the pandemic among older Veterans. Acceptance and Commitment Therapy (ACT) decreases emotional suffering, improves well-being, promotes and supports healthy behavior changes, and treats a wide range of diagnoses by increasing psychological flexibility through mindfulness, acceptance, and values-based behaviors. Higher psychological flexibility has been associated with pandemic-related coping and well-being. Randomized studies of ACT with older adults are few but promising, and most research studies with this population have used a group format. While research on telehealth delivery of ACT for older adults is limited, preliminary results indicate it is feasible and as effective as ACT delivered in person.
Specific Aim: The proposed study will pilot a 10-session telehealth Pandemic ACT group intervention (i.e., Pan-ACT group) with Veterans ages 65 and older who are experiencing pandemic-related emotional and physical distress.
Methods and Procedures: Twenty-five older Veterans will be enrolled in this single-arm feasibility pilot trial. The intervention will be delivered weekly in 90-minute sessions of groups of four to five Veterans. Feasibility and acceptability of study procedures will be measured by referred-to-enrolled rate, telehealth access and capability, electronic data collection of outcome measures, and qualitative feedback on data collection procedures and measures. Feasibility and acceptability of the intervention will be measured by attendance; attrition; homework completion; participant ratings of the intervention's feasibility, acceptability, and fit; qualitative feedback; and treatment fidelity. Preliminary responsiveness of outcomes measures will be explored. Participants will complete measures of pandemic-related emotional and physical distress, psychological flexibility, depression, anxiety, social connectedness, perceived health, functional impairment, and meaningful engagement at baseline, posttreatment, and one-month follow-up. A brief midpoint assessment at week 5 of the group will consist of measures of social connectedness and functional impairment. Qualitative data will be gathered on perceived efficacy to implement intervention skills and specific emotional or behavioral changes participants have noticed in themselves as a result of the intervention.
Conclusion: The telehealth Pan-ACT Group is a mental and behavioral health rehabilitation intervention that focuses on helping older Veterans develop or recover coping skills that were lost or are no longer effective during the ongoing COVID-19 pandemic. The proposed study address a major research and clinical gap by gathering new knowledge for an urgent need, which will inform the development of a full-scale randomized controlled trial to evaluate the intervention's effectiveness.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Alabama
-
Tuscaloosa, Alabama, United States, 35404-5015
- Tuscaloosa VA Medical Center, Tuscaloosa, AL
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Veteran
- receives care at Tuscaloosa VA Medical Center
- score of 9 or greater on the COVID-19 Mental Health Impacts Scale
- English speaking
- provides written informed consent
Exclusion Criteria:
- diagnosis of dementia
- score of 31 or less on the Modified Telephone Interview for Cognitive Status
- actively suicidal or homicidal
- actively psychotic
- unstable medical condition
- active substance use disorder
- currently participating in another CBT-based intervention
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Veterans
Veterans will be ages 65 and older, cognitively intact, and experiencing pandemic-related stress.
|
Pan-ACT is a 10-session, closed group, transdiagnostic intervention for older adults.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Acceptability of study protocol - retention
Time Frame: Through study completion, approximately 2 years
|
Rate of study completion
|
Through study completion, approximately 2 years
|
|
Feasibility of study protocol - telehealth
Time Frame: Through study completion, approximately 2 years
|
Percent of participants who have telehealth capability for duration of intervention
|
Through study completion, approximately 2 years
|
|
Acceptability of intervention - group attendance
Time Frame: Through study completion, approximately 2 years
|
Percent of participants who attend 70% or more of intervention sessions
|
Through study completion, approximately 2 years
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Acceptability of study protocol - enrollment
Time Frame: Throughout active enrollment period, approximately 1.5 years
|
Referred to enrolled rate
|
Throughout active enrollment period, approximately 1.5 years
|
|
Acceptability of study protocol - assessment completion
Time Frame: Through study completion, approximately 2 years
|
Rate of completed study assessments
|
Through study completion, approximately 2 years
|
|
Feasibility of study protocol - timeline
Time Frame: Through study completion, approximately 2 years
|
Percent of group cohorts that start as scheduled on timeline
|
Through study completion, approximately 2 years
|
|
Acceptability of intervention - homework completion
Time Frame: Through study completion, approximately 2 years
|
Percent of completed home practice exercises
|
Through study completion, approximately 2 years
|
|
Feasibility of intervention - treatment fidelity
Time Frame: Through study completion, approximately 2 years
|
Ratings on ACT Fidelity Measures
|
Through study completion, approximately 2 years
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Lori Lynne Davis, MD AB, Tuscaloosa VA Medical Center, Tuscaloosa, AL
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- D3898-P
- 1I21RX003898-01A1 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Psychological Stress
-
University of Thi-QarCompletedPsychological Stress | Academic StressIraq
-
Amsterdam UMC, location VUmcRigshospitalet, Denmark; Universitätsklinikum Hamburg-EppendorfNot yet recruitingStress | Stress and Burnout | Stress BiomarkersGermany, Denmark
-
New York State Psychiatric InstituteJohnson & JohnsonCompletedPsychological Stress in PregnancyUnited States
-
Hacettepe UniversityCompletedStressTurkey (Türkiye)
-
Baylor UniversityNational Heart, Lung, and Blood Institute (NHLBI)CompletedAcute Psychological StressUnited States
-
Örebro University, SwedenCompletedPsychological Stress Due to SkydivingSweden
-
Universität Duisburg-EssenRecruitingStress | Burnout | Burnout Syndrome | Stress ResilienceGermany
-
Amrita Vishwa VidyapeethamAmrita Viswa VidyapeethamCompletedCovid Related Psychological StressIndia
-
Massachusetts General HospitalCompletedStress | Emotional Stress | Psychological Stress | Social Stress | Life StressUnited States
-
University of WashingtonNational Institute on Alcohol Abuse and Alcoholism (NIAAA)Not yet recruitingPsychological Stress | Social Interaction
Clinical Trials on Pandemic Acceptance and Commitment Therapy (Pan-ACT)
-
Anne Roche, MACompletedQuality of Life | AgingUnited States
-
Belfast Health and Social Care TrustQueen's University, Belfast; Trauma and Orthopaedics Research CharityNot yet recruitingKnee Osteoarthritis | Total Knee ArthroplastyUnited Kingdom
-
St. Olavs HospitalNorwegian University of Science and TechnologyRecruitingPost-Concussion Syndrome | Post-Traumatic HeadacheNorway
-
Indiana UniversityRegenstrief Institute, Inc.CompletedAnxiety | Anxiety Disorders and Symptoms | Caregiver BurnoutUnited States
-
Central Finland Hospital DistrictUniversity of Jyvaskyla; Finnish Diabetes AssociationCompleted
-
King's College Hospital NHS TrustKing's College London; Barts & The London NHS Trust; University Hospital Southampton... and other collaboratorsCompleted
-
University of California, San FranciscoCompletedCancer RecurrenceUnited States
-
King's College LondonGuy's and St Thomas' NHS Foundation TrustRecruiting
-
University of Alabama at BirminghamWithdrawnDepression | Stroke | Stress | AnxietyUnited States
-
Massachusetts General HospitalOrganization for Autism ResearchCompleted